GFAP and Alexander disease: In parallel to these findings, mutations effecting C-terminal domain of GFAP-induced excessive filament aggregation, decreased solubility, caspase-3 activation, and excessive astrocyte loss, all together forming the underlying pathological basis for manifestation of Alexandria Disease (AxD)) [53].